SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 30th, 2015 • Cellectar Biosciences, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of September __, 2015, between Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 30th, 2015 • Cellectar Biosciences, Inc. • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of September__, 2015, between Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
SERIES A COMMON STOCK PURCHASE WARRANTCellectar Biosciences, Inc. • September 30th, 2015 • Pharmaceutical preparations
THIS SERIES A COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after March __, 2016 (the “Initial Exercise Date”) and on or prior to the close of business on the _____ year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SERIES B PREFUNDED COMMON STOCK PURCHASE WARRANT cellectar biosciences, inc.Cellectar Biosciences, Inc. • September 30th, 2015 • Pharmaceutical preparations • Delaware
THIS SERIES B PREFUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price for the exercise of the Warrant Shares, $______ in the aggregate (the “Aggregate Exercise Price”), was fully paid at Close and no additional consideration is required to be paid by the Holder upon exercise of this Warrant. The “Per Warrant Share Purchase Price” of each Warrant Share shall be determined by dividing the Aggregate Exercise Price by the number of Wa
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • September 30th, 2015 • Cellectar Biosciences, Inc. • Pharmaceutical preparations • New York
